Image de couverture de livre

The use of Pharmacokinetic and Pharmacodynamics to evaluate The recommended dosing regimens of Cefoperazone-Sulbactam in patients with hospital-Acquired Pneumonia

Thesis (Ph.D.)--Chulalongkorn University, 2007

Enregistré dans:

Détails bibliographiques
Auteur principal:	Narawadee Niamhun (Auteur)
Autres auteurs:	Duangchit Panomvana (Collaborateur), Pintip Pongpech (Collaborateur), Athavudh Deesomchok (Collaborateur), Chulalongkorn University. Faculty of Pharmaceutical Science (Collaborateur)
Format:	Livre
Publié:	Chulalongkorn University, 2014-03-25T12:17:55Z.
Sujets:	Thesis
Accès en ligne:	Connect to this object online.
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis
par: Chienhsiu Huang, et autres
Publié: (2024)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
par: Ariturk Ender, et autres
Publié: (2003)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
par: Tetsushu Onita, et autres
Publié: (2023)

In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
par: Ming-Jen Sheu, et autres
Publié: (2020)

Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
par: Ling Zhou, et autres
Publié: (2019)

Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease
par: Chien-Ming Chao, et autres
Publié: (2022)

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
par: Xi-Wei Ji, et autres
Publié: (2022)

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam
par: Yan-Jing Qu, et autres
Publié: (2016)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
par: Xueting Wang, et autres
Publié: (2023)

Activity Of Piperacillin/Tazobactam And Cefoperazone/Sulbactam Against Pathogenic Isolates Of Enterobacteriaceae
par: Qamar un nisa Naz, et autres
Publié: (2024)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against <i>Acinetobacter baumannii</i> in Patients with Hospital-Acquired Pneumonia
par: Yingjie Zhou, et autres
Publié: (2022)

CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS
par: E.B. Pavlinova, et autres
Publié: (2006)

CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS
par: E.B. Pavlinova, et autres
Publié: (2006)

Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature
par: Gowthami Sai Kogilathota Jagirdhar, et autres
Publié: (2023)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
par: Xingchen Bian, et autres
Publié: (2024)

Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency
par: Xu J, et autres
Publié: (2024)

Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study
par: Ruiqiu Zhang, et autres
Publié: (2023)

Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone-Sulbactam
par: Chien-Hsiang Tai, et autres
Publié: (2022)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
par: Yaxin Fan, et autres
Publié: (2022)

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs
par: Tridib Chaira, et autres
Publié: (2023)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
par: Lei Zhang, et autres
Publié: (2023)

Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia
par: Munjal Patel, et autres
Publié: (2022)

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
par: Frontiers Production Office
Publié: (2024)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
par: Yuancheng Chen, et autres
Publié: (2023)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against <it>Acinetobacter baumannii </it>strains in terms of bactericidal efficacy and resistance selection
par: Gundes Sibel, et autres
Publié: (2004)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
par: Hideo Kato, et autres
Publié: (2022)

Cefoperazone induced hypersensitivity vasculitis
par: Katiyar Subodh, et autres
Publié: (2009)

Preparation of Aditoprim Injection against <i>Streptococcus suis</i> in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling
par: Wei Qu, et autres
Publié: (2022)

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
par: Yue-E Wu, et autres
Publié: (2022)

Cefoperazone induces esterase B expression by EstR and esterase B enhances cefoperazone activity at the periplasm
par: Neal Toewiwat, et autres
Publié: (2020)

The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs
par: Yuanyuan Yuan, et autres
Publié: (2023)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
par: Frost C, et autres
Publié: (2018)

Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach
par: Abbasi MY, et autres
Publié: (2023)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
par: Noriyuki Ishihara, et autres
Publié: (2020)

Population pharmacokinetic‐pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
par: Yun Seob Jung, et autres
Publié: (2024)

Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
par: Saeed Alqahtani, et autres
Publié: (2021)

Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose
par: Wenyuan Xiong, et autres
Publié: (2021)

Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single‐center retrospective observational study
par: Tomokazu Suzuki, et autres
Publié: (2021)

A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
par: Warren E. Rose, et autres
Publié: (2020)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
par: Mwila Mulubwa, et autres
Publié: (2020)